Molecular Targets and Associated Potential Pathways of Danlu Capsules in Hyperplasia of Mammary Glands Based on Systems Pharmacology

Table 1

Compounds in DLCs that satisfied the criteria of OB ≥ 30% and DL ≥ 0.18.

Herbs	Total	OB ≥ 30%	DL ≥ 0.18
FC	114	69 (64.2)	19 (24.5)
CM	55	26 (28.3)	11 (17.4)
RPR	119	58 (48.9)	29 (15.3)
RC	222	142 (64.0)	15 (6.8)
TL	48	27 (56.3)	7 (14.6)
RPMP	28	11 (39.3)	8 (28.6)
CC	8	0 (0.0)	0 (0.0)
CG	9	0 (0.0)	(0.0)